HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives-Reference-Cited by-同舟云学术

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives

Published:2016-08-12 Issue:42 Volume:7 Page:69060-69074
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Fanotto Valentina¹,Ongaro Elena¹,Rihawi Karim²,Avallone Antonio³,Silvestris Nicola⁴,Fornaro Lorenzo⁵,Vasile Enrico⁵,Antonuzzo Lorenzo⁶,Leone Francesco⁷,Rosati Gerardo⁸,Giuliani Francesco⁴,Bordonaro Roberto⁹,Scartozzi Mario¹⁰,Maglio Giovanna De¹¹,Negri Francesca V.¹²,Fasola Gianpiero¹,Aprile Giuseppe¹

Affiliation:

1. Department of Oncology, University and General Hospital, Udine, Italy

2. Department of Oncology, S.Orsola-Malpighi Hospital, Bologna, Italy

3. Gastrointestinal Medical Oncology Unit, National Cancer Institute “Fondazione Giovanni Pascale”-IRCCS, Napoli, Italy

4. Department of Oncology, National CancerInstitute “Giovanni Paolo II”-IRCSS, Bari, Italy

5. Unit of Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

6. Department of Oncology, Careggi Hospital, Firenze, Italy

7. Department of Medical Oncology, University of Torino, Candiolo Cancer Institute-FPO-IRCCS, Torino, Italy

8. Medical Oncology Unit, San Carlo Hospital, Potenza, Italy

9. Department of Oncology, ARNAS Garibaldi, Catania, Italy

10. Department of Oncology, University Hospital, Cagliari, Italy

11. Department of Pathology, University and General Hospital, Udine, Italy